Crossref
Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy
Genetics and Molecular Research · 2025 · 24 (1)
DOI: 10.4238/z2qb9g57 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics and Molecular Research, 2025. Verfasst von Tianling Liao und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liao, T., Huang, Q., Tang, H., Xie, H., Liao, K., Su, Z., Ban, C., Cheng, Z., & Yi, X. (2025). Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy. Genetics and Molecular Research, 24(1). https://doi.org/10.4238/z2qb9g57
Vancouver
Liao T, Huang Q, Tang H, Xie H, Liao K, Su Z, et al. Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy. Genetics and Molecular Research. 2025;24(1). doi:10.4238/z2qb9g57
BibTeX
@article{Liao2025,
author = {Liao, Tianling and Huang, Qingming and Tang, Han and Xie, Huadong and Liao, Kangji and Su, Zhengwei and Ban, Chengjie and Cheng, Zhi and Yi, Xianlin},
title = {Pan-cancer analysis of ACHE as a biomarker forcancer prognosis and immunotherapy},
journal = {Genetics and Molecular Research},
year = {2025},
volume = {24},
number = {1},
doi = {10.4238/z2qb9g57}
}
EUVIMED